Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""glioma"" wg kryterium: Temat


Tytuł :
Brainstem Infiltration Predicts Survival in Patients With High-grade Gliomas Treated With Chemoradiotherapy.
Autorzy :
Anami S; Department of Radiology, Wakayama Medical University, Wakayama, Japan; .
Fukai J; Department of Neurological Surgery, Wakayama Medical University, Wakayama, Japan.
Hama M; Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Awaya A; Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Inagaki T; Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Chiba T; Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Noda Y; Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Kanemura Y; Department of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Japan.; Department of Neurosurgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Nakao N; Department of Neurological Surgery, Wakayama Medical University, Wakayama, Japan.
Sonomura T; Department of Radiology, Wakayama Medical University, Wakayama, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 May; Vol. 41 (5), pp. 2583-2589.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Stem/*immunology
DNA Modification Methylases/*genetics
DNA Repair Enzymes/*genetics
Glioma/*drug therapy
Glioma/*radiotherapy
Tumor Suppressor Proteins/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Basal Ganglia/immunology ; Basal Ganglia/pathology ; Brain Stem/pathology ; Chemoradiotherapy/adverse effects ; Disease-Free Survival ; Female ; Gene Expression Regulation, Neoplastic/immunology ; Glioma/immunology ; Glioma/pathology ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Neoplasm Grading ; Promoter Regions, Genetic/genetics
Czasopismo naukowe
Tytuł :
Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models.
Autorzy :
Vitanza NA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Biery MC; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Myers C; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Ferguson E; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Zheng Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Girard EJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Przystal JM; University Children's Hospital Zurich, Zurich, Switzerland.
Park G; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Noll A; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Molecular and Cellular Biology Graduate Program and Medical Scientist Training Program, University of Washington, Seattle, Washington, USA.
Pakiam F; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Winter CA; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Morris SM; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Sarthy J; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Cole BL; Department of Laboratories, Seattle Children's Hospital, Seattle, Washington, USA.; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Leary SES; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Crane C; Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington, USA.
Lieberman NAP; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, Washington, USA.
Mueller S; University Children's Hospital Zurich, Zurich, Switzerland.; University of California San Francisco, San Francisco, California, USA.
Nazarian J; University Children's Hospital Zurich, Zurich, Switzerland.; Department of Genetic Medicine Research, Children's National Medical Center, Washington DC, USA.
Gottardo R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Statistics, University of Washington, Seattle, Washington, USA.
Brusniak MY; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Mhyre AJ; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Olson JM; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2021 Mar 25; Vol. 23 (3), pp. 376-386.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Stem Neoplasms*
Glioma*/drug therapy
Glioma*/genetics
Biopsy ; Histones/genetics ; Humans ; Mutation ; Panobinostat
Czasopismo naukowe
Tytuł :
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study.
Autorzy :
Rydén I; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Blå stråket 7, 3 tr, 413 45, Gothenburg, Sweden. .
Thurin E; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Blå stråket 7, 3 tr, 413 45, Gothenburg, Sweden.
Carstam L; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Blå stråket 7, 3 tr, 413 45, Gothenburg, Sweden.; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
Smits A; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Blå stråket 7, 3 tr, 413 45, Gothenburg, Sweden.
Gulati S; Department of Neurosurgery, St.Olavs University Hospital HF, Trondheim, Norway.
Henriksson R; Department of Radiation Sciences and Oncology, University of Umea, Umeå, Sweden.
Salvesen Ø; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Store Jakola A; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg, Sahlgrenska Academy, Blå stråket 7, 3 tr, 413 45, Gothenburg, Sweden.; Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Neurosurgery, St.Olavs University Hospital HF, Trondheim, Norway.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Mar 08; Vol. 21 (1), pp. 248. Date of Electronic Publication: 2021 Mar 08.
Typ publikacji :
Journal Article
MeSH Terms :
Anxiety/*epidemiology
Brain Neoplasms/*surgery
Depression/*epidemiology
Glioma/*surgery
Seizures/*epidemiology
Adult ; Age Factors ; Anti-Anxiety Agents/therapeutic use ; Anticonvulsants/therapeutic use ; Antidepressive Agents/therapeutic use ; Anxiety/drug therapy ; Anxiety/etiology ; Anxiety/psychology ; Brain Neoplasms/diagnosis ; Case-Control Studies ; Depression/drug therapy ; Depression/etiology ; Depression/psychology ; Drug Prescriptions/statistics & numerical data ; Female ; Glioma/complications ; Glioma/diagnosis ; Glioma/psychology ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Postoperative Period ; Preoperative Period ; Registries/statistics & numerical data ; Risk Factors ; Seizures/drug therapy ; Seizures/etiology ; Sex Factors ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Prognostic and predictive impact of MGMT promoter methylation in grade 3 gliomas.
Autorzy :
Haque W; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA. Electronic address: .
Thong E; Department of Psychology, Nova Southeastern University, Davie, FL, USA.
Andrabi S; Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, USA.
Verma V; Department of Emergency Medicine, Baylor College of Medicine, Houston, TX, USA.
Brian Butler E; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.
Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, Houston, TX, USA.
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 Mar; Vol. 85, pp. 115-121. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*genetics
Brain Neoplasms/*genetics
DNA Modification Methylases/*genetics
DNA Repair Enzymes/*genetics
Glioma/*genetics
Tumor Suppressor Proteins/*genetics
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/mortality ; Brain Neoplasms/pathology ; DNA Methylation/genetics ; Female ; Glioma/mortality ; Glioma/pathology ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Prognosis ; Promoter Regions, Genetic/genetics
Czasopismo naukowe
Tytuł :
Voxelwise and Patientwise Correlation of F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes.
Autorzy :
Tatekawa H; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Hagiwara A; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Yao J; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Bioengineering, Henry Samueli School of Engineering, UCLA, Los Angeles, California.
Oughourlian TC; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.; Neuroscience Interdepartmental Program, David Geffen School of Medicine, UCLA, Los Angeles, California.
Ueda I; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Uetani H; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Raymond C; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Lai A; UCLA Neuro-Oncology Program, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, California; and.
Cloughesy TF; UCLA Neuro-Oncology Program, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, California; and.
Nghiemphu PL; UCLA Neuro-Oncology Program, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, California; and.
Liau LM; UCLA Neuro-Oncology Program, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Neurosurgery, David Geffen School of Medicine, UCLA, Los Angeles, California.
Pope WB; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Salamon N; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.
Ellingson BM; UCLA Brain Tumor Imaging Laboratory, Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, UCLA, Los Angeles, California .; Department of Radiological Science, David Geffen School of Medicine, UCLA, Los Angeles, California.; Department of Bioengineering, Henry Samueli School of Engineering, UCLA, Los Angeles, California.; Neuroscience Interdepartmental Program, David Geffen School of Medicine, UCLA, Los Angeles, California.; UCLA Neuro-Oncology Program, David Geffen School of Medicine, UCLA, Los Angeles, California.
Pokaż więcej
Źródło :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2021 Mar; Vol. 62 (3), pp. 319-325. Date of Electronic Publication: 2020 Jul 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cerebral Blood Volume*
Positron-Emission Tomography*
Brain Neoplasms/*diagnostic imaging
Brain Neoplasms/*physiopathology
Dihydroxyphenylalanine/*analogs & derivatives
Glioma/*diagnostic imaging
Glioma/*physiopathology
Brain Neoplasms/pathology ; Brain Neoplasms/therapy ; Diffusion ; Female ; Glioma/pathology ; Glioma/therapy ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Dual-layer detector spectral CT-a new supplementary method for preoperative evaluation of glioma.
Autorzy :
Yingying L; Department of Radiology, Beijing Chaoyang Hospital, Capital Medical University, No. 8 Gongti South Road, Beijing, 100024, China.
Zhe Z; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China.
Xiaochen W; Department of Radiology, Beijing Tiantan Hospital, Capital Medical University, No.119 Fanyang Road, Fengtai District, Beijing, 100070, China.
Xiaomei L; CT Clinical Science, Philips Healthcare, Shenyang, 110016, China.
Nan J; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Advanced Innovation Center for Big Data-Based Precision Medicine, China. Electronic address: .
Shengjun S; Department of Neuroradiology, Beijing Neurosurgical Institute, No.119 Fanyang Road, Fengtai District, Beijing, 100070, China. Electronic address: .
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2021 May; Vol. 138, pp. 109649. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Glioma*/diagnostic imaging
Glioma*/surgery
Humans ; Isocitrate Dehydrogenase/genetics ; Mutation ; Neoplasm Grading ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Endoplasmic Reticulum Stress Contributes to Gefitinib-Induced Apoptosis in Glioma.
Autorzy :
Chang CY; Department of Surgery, Feng Yuan Hospital, Taichung 420, Taiwan.
Pan PH; Department of Pediatrics, Tungs' Taichung MetroHarbor Hospital, Taichung 435, Taiwan.; Department of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan.
Wu CC; Department of Anesthesiology, Taichung Veterans General Hospital, Taichung 407, Taiwan.
Liao SL; Department of Medical Research, Taichung Veterans General Hospital, Taichung 407, Taiwan.
Chen WY; Department of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan.
Kuan YH; Department of Pharmacology, Chung Shan Medical University, Taichung 402, Taiwan.
Wang WY; Department of Nursing, HungKuang University, Taichung 433, Taiwan.
Chen CJ; Department of Medical Research, Taichung Veterans General Hospital, Taichung 407, Taiwan.; Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung 404, Taiwan.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Apr 11; Vol. 22 (8). Date of Electronic Publication: 2021 Apr 11.
Typ publikacji :
Journal Article
MeSH Terms :
Apoptosis/*drug effects
Endoplasmic Reticulum Stress/*drug effects
Gefitinib/*pharmacology
Glioma/*drug therapy
Signal Transduction/*drug effects
Cell Line, Tumor ; Glioma/metabolism ; Glioma/pathology ; Humans ; Neoplasm Proteins/metabolism
Czasopismo naukowe
Tytuł :
A prospective interventional study evaluating seizure activity during a radiotherapy course for high-grade gliomas (SURF-ROGG).
Autorzy :
Rades D; Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. .
Witteler J; Department of Radiation Oncology, University of Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.
Olbrich D; The Centre for Clinical Trials Lübeck, Lübeck, Germany.
Trillenberg P; Department of Neurology, University of Lübeck, Lübeck, Germany.
Schild SE; Department of Radiation Oncology, Mayo Clinic Scottsdale, Scottsdale, AZ, USA.
Tvilsted S; Research Projects and Clinical Optimization, Zealand University Hospital, Koege, Denmark.
Kjaer TW; Neurological Department, Zealand University Hospital, Roskilde, Denmark.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Apr 09; Vol. 21 (1), pp. 386. Date of Electronic Publication: 2021 Apr 09.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms/*complications
Brain Neoplasms/*pathology
Cranial Irradiation/*adverse effects
Glioma/*complications
Glioma/*pathology
Seizures/*diagnosis
Seizures/*etiology
Anticonvulsants/therapeutic use ; Brain Neoplasms/radiotherapy ; Chemoradiotherapy ; Cranial Irradiation/methods ; Disease Management ; Disease Susceptibility ; Electroencephalography ; Female ; Glioma/radiotherapy ; Humans ; Male ; Neoplasm Grading ; Neoplasm Staging ; Seizures/therapy ; Symptom Assessment ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy.
Autorzy :
Szychot E; Oak Centre for Children and Young People, Royal Marsden NHS Foundation Trust Hospital, Sutton, UK.; Harley Street Children's Hospital, London, UK.
Walker D; Harley Street Children's Hospital, London, UK.; Children's Brain Tumour Research Centre, University of Nottingham, Nottingham, UK.
Collins P; Harley Street Children's Hospital, London, UK.
Hyare H; Harley Street Children's Hospital, London, UK.; Department of Neuroradiology, University College London Hospitals NHS Foundation Trust, London, UK.
Shankar A; Harley Street Children's Hospital, London, UK.; Teenager and Young Adult Cancer Service, University College London Hospitals NHS Foundation Trust, London, UK.
Bienemann A; Functional Neurosurgery Group, Clinical Neurosciences, University of Bristol, Bristol, UK.
Hollingworth M; Functional Neurosurgery Group, Clinical Neurosciences, University of Bristol, Bristol, UK.
Gill S; Harley Street Children's Hospital, London, UK. .; Functional Neurosurgery Group, Clinical Neurosciences, University of Bristol, Bristol, UK. .
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2021 Apr; Vol. 26 (4), pp. 647-658. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents*/therapeutic use
Diffuse Intrinsic Pontine Glioma*
Glioma*/drug therapy
Glioma*/radiotherapy
Carboplatin/adverse effects ; Child ; Convection ; Humans ; Pons ; Retrospective Studies ; Valproic Acid/adverse effects ; Young Adult
Czasopismo naukowe
Tytuł :
Development of MR-based preoperative nomograms predicting DNA copy number subtype in lower grade gliomas with prognostic implication.
Autorzy :
Zhang S; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Wu S; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Wan Y; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Ye Y; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Zhang Y; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Ma Z; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Guo Q; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China.
Zhang H; Guangdong General Hospital, Guangzhou, People's Republic of China.
Xu L; The Second Affiliated Hospital of Guangzhou University of Chinese Medicine & Guangdong Provincial Hospital of Chinese Medicine, 111 Da De Lu, Guangzhou, 510120, Guangdong Province, People's Republic of China. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Apr; Vol. 31 (4), pp. 2094-2105. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Glioma*/diagnostic imaging
Glioma*/genetics
Nomograms*
DNA ; DNA Copy Number Variations ; Humans ; Magnetic Resonance Imaging ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
An MRI-based radiomics signature as a pretreatment noninvasive predictor of overall survival and chemotherapeutic benefits in lower-grade gliomas.
Autorzy :
Wang J; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, 250012, Shandong, China.; Institute for Medical Dataology, Shandong University, 12550 Erhuandong Road, Jinan, 250002, Shandong, China.
Zheng X; Department of Radiology, The Linyi People's Hospital, Shandong University, 27 Jiefang Road, Linyi, 276000, Shandong, China.
Zhang J; Cancer Center & The Research Center Of Function Image on Brain Tumor, The Linyi People's Hospital, Shandong University, 27 Jiefang Road, Linyi, 276000, Shandong, China.
Xue H; Department of Neurosurgery, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, Shandong, China.
Wang L; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, 250012, Shandong, China.; Institute for Medical Dataology, Shandong University, 12550 Erhuandong Road, Jinan, 250002, Shandong, China.
Jing R; Department of Radiology, Second Hospital of Shandong University, 247 Beiyuan Road, Jinan, 250000, Shandong, China.
Chen S; Division of Biostatistics and Bioinformatics, Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, 55 Wade Avenue, Baltimore, MD, 20742, USA.
Che F; Neurology Department & The Research Center of Function Image on Brain Tumor, The Linyi People's Hospital, Shandong University, 27 Jiefang Road, Linyi, 276000, Shandong, China.
Heng X; Neurology Department & The Research Center of Function Image on Brain Tumor, The Linyi People's Hospital, Shandong University, 27 Jiefang Road, Linyi, 276000, Shandong, China.
Li G; Department of Neurosurgery, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, Shandong, China. .
Xue F; Department of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, 44 Wenhuaxi Road, Jinan, 250012, Shandong, China. .; Institute for Medical Dataology, Shandong University, 12550 Erhuandong Road, Jinan, 250002, Shandong, China. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2021 Apr; Vol. 31 (4), pp. 1785-1794. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :
Journal Article
MeSH Terms :
Glioma*/diagnostic imaging
Glioma*/drug therapy
Magnetic Resonance Imaging*
Humans ; Nomograms ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Human TERT promoter mutations as a prognostic biomarker in glioma.
Autorzy :
Powter B; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia. .
Jeffreys SA; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.
Sareen H; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; Western Clinical School, University of New South Wales South, Goulburn St, Liverpool, NSW, 2170, Australia.
Cooper A; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.; Cancer Therapy Centre, Liverpool Hospital, Elizabeth St and Goulburn St, Liverpool, NSW, 2170, Australia.
Brungs D; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; School of Medicine, University of Wollongong, Wollongong, NSW, 2522, Australia.
Po J; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.
Roberts T; School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.; Western Clinical School, University of New South Wales South, Goulburn St, Liverpool, NSW, 2170, Australia.
Koh ES; Western Clinical School, University of New South Wales South, Goulburn St, Liverpool, NSW, 2170, Australia.; Cancer Therapy Centre, Liverpool Hospital, Elizabeth St and Goulburn St, Liverpool, NSW, 2170, Australia.
Scott KF; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.
Sajinovic M; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.
Vessey JY; Cancer Therapy Centre, Liverpool Hospital, Elizabeth St and Goulburn St, Liverpool, NSW, 2170, Australia.
de Souza P; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.; Western Clinical School, University of New South Wales South, Goulburn St, Liverpool, NSW, 2170, Australia.; Cancer Therapy Centre, Liverpool Hospital, Elizabeth St and Goulburn St, Liverpool, NSW, 2170, Australia.; School of Medicine, University of Wollongong, Wollongong, NSW, 2522, Australia.
Becker TM; Centre for Circulating Tumour Cell Diagnostics and Research, Ingham Institute for Applied Medical Research, 1 Campbell St, Liverpool, NSW, 2170, Australia.; School of Medicine, Western Sydney University, Campbelltown, NSW, 2560, Australia.; Western Clinical School, University of New South Wales South, Goulburn St, Liverpool, NSW, 2170, Australia.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Apr; Vol. 147 (4), pp. 1007-1017. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Mutation*
Biomarkers, Tumor/*genetics
Brain Neoplasms/*pathology
Glioma/*pathology
Telomerase/*genetics
Brain Neoplasms/genetics ; Brain Neoplasms/therapy ; Glioma/genetics ; Glioma/therapy ; Humans ; Prognosis
Czasopismo naukowe
Tytuł :
The diagnostic value of intravoxel incoherent motion imaging in differentiating high-grade from low-grade gliomas: a systematic review and meta-analysis.
Autorzy :
Luo H; Department of Radiology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
He L; Department of Radiology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Cheng W; Department of Radiology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Gao S; Department of Radiology, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation base of Child development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, China.
Pokaż więcej
Źródło :
The British journal of radiology [Br J Radiol] 2021 May 01; Vol. 94 (1121), pp. 20201321.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Microcirculation*
Brain Neoplasms/*diagnostic imaging
Glioma/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Area Under Curve ; Brain Neoplasms/blood supply ; Brain Neoplasms/pathology ; Confidence Intervals ; Diffusion Magnetic Resonance Imaging ; Glioma/blood supply ; Glioma/pathology ; Humans ; Neoplasm Grading ; Odds Ratio ; Publication Bias ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Feasibility and Therapeutic Potential of Peptide Receptor Radionuclide Therapy for High-Grade Gliomas.
Autorzy :
Nemati R; From the Department of Neurology.
Shooli H; The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences.
Rekabpour SJ; Department of Oncology, Salman Farsi Hospital, Bushehr, Iran.
Ahmadzadehfar H; Department of Nuclear Medicine, Klinikum Westfalen, Dortmund, Germany.
Jafari E; The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences.
Ravanbod MR; Departments of Oncology.
Amini A; Cardiology, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr.
Nemati A; Department of Neurosurgery, Shiraz Hospital, Shiraz.
Ghasemi M; Departments of Neurosurgery.
Keshmiri S; Anesthesiology, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences, Bushehr.
Dadgar H; Cancer Research Center, Razavi Hospital, Imam Reza International University, Mashhad, Iran.
Assadi M; The Persian Gulf Nuclear Medicine Research Center, Department of Molecular Imaging and Radionuclide Therapy, Bushehr Medical University Hospital, School of Medicine, Bushehr University of Medical Sciences.
Pokaż więcej
Źródło :
Clinical nuclear medicine [Clin Nucl Med] 2021 May 01; Vol. 46 (5), pp. 389-395.
Typ publikacji :
Journal Article
MeSH Terms :
Glioma/*pathology
Glioma/*radiotherapy
Receptors, Somatostatin/*metabolism
Adult ; Aged ; Coordination Complexes/therapeutic use ; Feasibility Studies ; Female ; Glioma/metabolism ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Octreotide/analogs & derivatives ; Octreotide/therapeutic use ; Organometallic Compounds/therapeutic use ; Pilot Projects ; Prospective Studies ; Quality of Life
Czasopismo naukowe
Tytuł :
Corilagin induces apoptosis and autophagy in NRF2‑addicted U251 glioma cell line.
Autorzy :
Liu J; Department of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Qin X; Department of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Ma W; Department of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Jia S; Department of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Zhang X; Department of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Yang X; Department of Orthopaedic Surgery, Orthopaedic Research Labs, University of Virginia, Charlottesville, VA 22908, USA.
Pan D; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, USA.
Jin F; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA 22908, USA.
Pokaż więcej
Źródło :
Molecular medicine reports [Mol Med Rep] 2021 May; Vol. 23 (5). Date of Electronic Publication: 2021 Mar 24.
Typ publikacji :
Journal Article
MeSH Terms :
Autophagy/*drug effects
Glioma/*drug therapy
Glucosides/*pharmacology
Hydrolyzable Tannins/*pharmacology
NF-E2-Related Factor 2/*genetics
Adult ; Aged ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Glioma/genetics ; Glioma/pathology ; Humans ; Male ; Middle Aged ; Signal Transduction/drug effects ; Temozolomide/pharmacology
Czasopismo naukowe
Tytuł :
Primary application of mean apparent propagator-MRI diffusion model in the grading of diffuse glioma.
Autorzy :
Wang P; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Weng L; Department of Pathology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Xie S; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
He J; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Ma X; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Li B; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Yuan P; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Wang S; MR Scientific Marketing, Siemens Healthineers, Shanghai, 201318, China. Electronic address: .
Zhang H; MR Scientific Marketing, Siemens Healthineers, Shanghai, 201318, China. Electronic address: .
Niu G; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Wu Q; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Gao Y; Department of Radiology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, 010059, China. Electronic address: .
Pokaż więcej
Źródło :
European journal of radiology [Eur J Radiol] 2021 May; Vol. 138, pp. 109622. Date of Electronic Publication: 2021 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Glioma*/diagnostic imaging
Diffusion Magnetic Resonance Imaging ; Humans ; Magnetic Resonance Imaging ; Neoplasm Grading ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
GASC1 promotes glioma progression by enhancing NOTCH1 signaling.
Autorzy :
Xiao Z; Department of Neurosurgery, Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Yang X; Department of General Practice, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Liu Z; Department of Neurosurgery, Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Shao Z; Department of Neurosurgery, Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Song C; Department of Neurosurgery, Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, Henan 471003, P.R. China.
Zhang K; Spine Tumor Center, Department of Orthopedic Oncology, Changzheng Hospital, Second Military Medical University, Shanghai 210011, P.R. China.
Wang X; Department of Urology, Carson International Cancer Centre, Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Centre, Shenzhen University, Shenzhen, Guangdong 518000, P.R. China.
Li Z; Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Pokaż więcej
Źródło :
Molecular medicine reports [Mol Med Rep] 2021 May; Vol. 23 (5). Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms/*metabolism
Glioma/*metabolism
Jumonji Domain-Containing Histone Demethylases/*metabolism
Receptor, Notch1/*metabolism
Animals ; Brain Neoplasms/drug therapy ; Brain Neoplasms/genetics ; Caffeic Acids/pharmacology ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Movement/genetics ; Cell Survival/drug effects ; Cell Survival/genetics ; Diamines/pharmacology ; Female ; Gene Expression Regulation, Neoplastic ; Glioma/drug therapy ; Glioma/genetics ; Humans ; Jumonji Domain-Containing Histone Demethylases/antagonists & inhibitors ; Jumonji Domain-Containing Histone Demethylases/genetics ; Male ; Mice, Nude ; RNA Interference ; Receptor, Notch1/antagonists & inhibitors ; Receptor, Notch1/genetics ; Signal Transduction/genetics ; Thiazoles/pharmacology ; Xenograft Model Antitumor Assays/methods
Czasopismo naukowe
Tytuł :
Long noncoding RNA DUXAP10 promotes the stemness of glioma cells by recruiting HuR to enhance Sox12 mRNA stability.
Autorzy :
Wu B; Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Yang C; Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Fang Y; International College, Guangdong University of Foreign Studies, Guangzhou, China.
Ding W; Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Zhang Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło :
Environmental toxicology [Environ Toxicol] 2021 May; Vol. 36 (5), pp. 840-849. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Journal Article
MeSH Terms :
Glioma*/genetics
RNA, Long Noncoding*/genetics
Cell Line, Tumor ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Humans ; RNA Stability ; SOXC Transcription Factors
Czasopismo naukowe
Tytuł :
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.
Autorzy :
Friedman GK; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Johnston JM; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Bag AK; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Bernstock JD; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Li R; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Aban I; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Kachurak K; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Nan L; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Kang KD; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Totsch S; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Schlappi C; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Martin AM; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Pastakia D; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
McNall-Knapp R; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Farouk Sait S; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Khakoo Y; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Karajannis MA; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Woodling K; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Palmer JD; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Osorio DS; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Leonard J; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Abdelbaki MS; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Madan-Swain A; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Atkinson TP; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Whitley RJ; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Fiveash JB; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Markert JM; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Gillespie GY; From the Department of Pediatrics, Divisions of Pediatric Hematology-Oncology (G.K.F., K.K., L.N., K.-D.K., S.T., C.S., A.M.-S.), Pediatric Allergy and Immunology (T.P.A.), and Pediatric Infectious Disease (R.J.W.), and the Departments of Neurosurgery (G.K.F., J.M.J., J.M.M., G.Y.G.), Pathology (R.L.), Biostatistics (I.A.), and Radiation Oncology (J.B.F.), University of Alabama at Birmingham, and Children's of Alabama (G.K.F., J.M.J., R.L., K.K., A.M.-S., T.P.A., R.J.W.) - both in Birmingham; the Department of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis (A.K.B.), and the Department of Pediatrics, Vanderbilt University Medical Center, Nashville (D.P.) - both in Tennessee; the Department of Neurosurgery, Brigham and Women's Hospital and Boston Children's Hospital, Harvard Medical School, Boston (J.D.B.); the Department of Pediatrics, Albert Einstein College of Medicine (A.M.M.), and the Departments of Pediatrics (S.F.S., Y.K., M.A.K.) and Neurology (Y.K.), Memorial Sloan Kettering Cancer Center - both in New York; the Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City (R.M.-K.); the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant (K.W., D.S.O., M.S.A.) and the Department of Pediatric Neurosurgery (J.L.), Nationwide Children's Hospital, and the Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center (J.D.P.) - both in Columbus; and the Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant, Washington University School of Medicine, St. Louis (M.S.A.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Apr 29; Vol. 384 (17), pp. 1613-1622. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Oncolytic Virotherapy*/adverse effects
Brain Neoplasms/*therapy
Glioma/*therapy
Adolescent ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/pathology ; Brain Neoplasms/radiotherapy ; Child ; Child, Preschool ; Combined Modality Therapy ; Female ; Glioma/diagnostic imaging ; Glioma/pathology ; Glioma/radiotherapy ; Humans ; Kaplan-Meier Estimate ; Killer Cells, Natural ; Leukocyte Count ; Male ; T-Lymphocytes
Czasopismo naukowe
Tytuł :
A logistic regression model for prediction of glioma grading based on radiomics.
Autorzy :
Sun X; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008. .
Liao W; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008.
Cao D; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008.
Zhao Y; School of Computer Science and Engineering, South China University of Technology, Guangzhou 510640, China.
Zhou G; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008.
Wang D; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008.
Mao Y; Department of Radiology, Xiangya Hospital, Central South University, Changsha 410008. .
Pokaż więcej
Transliterated Title :
基于影像组学的logistic回归模型预测胶质瘤分级.
Źródło :
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences [Zhong Nan Da Xue Xue Bao Yi Xue Ban] 2021 Apr 28; Vol. 46 (4), pp. 385-392.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms*/diagnostic imaging
Glioma*/diagnostic imaging
Humans ; Logistic Models ; Magnetic Resonance Imaging ; ROC Curve ; Retrospective Studies
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies